Cargill bets on mycoprotein with investment in ENOUGH and signs offtake agreement

Cargill has invested an undisclosed sum into Glasgow-based alt protein startup ENOUGH as a “top up” to its recent series C round and signed commercial offtake agreements to use and market ENOUGH’s ‘ABUNDA’ mycoprotein.

The investment is “on top of the [$43.6 million series C] funds raised last year” and will give Cargill “a minority single digit holding in the company,” ENOUGH CEO Jim Laird told AgFunderNews.

Co-located with a Cargill starch facility that supplies it with fermentable sugars as a feedstock, the ENOUGH facility in Sas van Gent in The Netherlands harvests its fungal biomass (mycoprotein) and removes most of the water via centrifuge. It then supplies that sugary wastewater to Cargill’s bioethanol facility next door in a zero-waste process.